Form D · Other Health Care
CERENOME, INC.
Houston, TX · CIK 0001095981
Offering snapshot reported Sep 18, 2026 · SEC filing
- Reported sold
- $3M Offering amount: $20M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 10, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 18, 2026 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
| May 22, 2020 | Initial | $300,000 | No comparison | 1 | SEC filing |
| Jun 30, 2009 | Initial | $4,251,700 | No comparison | 41 | SEC filing |
| Oct 30, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 22, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 22, 2002 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-598173
The Company agreed to issue senior secured convertible notes in the aggregate original principal amount of up to $21,276,596, and each of the notes, when issued, reflects an original issue discount of 6.0%.
Source: Form D, filed Sep 18, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ronald A. Andrews | Director |
| Christopher J Calhoun | Director, Executive |
| Howard Clowes | Director |
| Kyle Guse | Director |
| Richard J. Hawkins | Director |
| Paul W Hawran | Director |
| Marc H. Hedrick | Director, Executive |
| Ronald D Henriksen | Director |
| E Carmack Holmes, Md | Director |
| Robert Lenk | Director |
| Greg Petersen | Director |
| David M Rickey | Director |
| Mark E Saad | Executive |
| Andrew Sims | Executive |
| An Van Es Johansson | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
6420 Levit Green Boulevard Suite 310
Houston, TX, 77021
Houston, TX, 77021